Basal cell carcinoma - diagnosis
Małgorzata Mackiewicz-Wysocka1, Monika Bowszyc-Dmochowska1, Daria Strzelecka-Węklar1
1Chair and Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland.
Contemporary Oncology (Poznan, Poland)
|March 5, 2014
Summary
Basal cell carcinoma, the most common skin cancer, often affects sun-exposed areas and has a high recurrence rate. Accurate diagnosis is crucial for effective treatment and to prevent disfigurement.
Area of Science:
- Dermatology
- Oncology
Background:
- Basal cell carcinoma (BCC) is the most prevalent skin malignancy in Caucasians.
- It typically develops on sun-exposed skin, with increasing incidence and morbidity.
- While metastasis is rare, BCC can cause significant tissue disfigurement and cosmetic issues.
Purpose of the Study:
- To highlight the diagnostic challenges in basal cell carcinoma.
- To emphasize the importance of accurate subtyping for appropriate treatment.
- To address the significant issue of high recurrence rates in BCC management.
Main Methods:
- Clinical diagnosis is the primary method.
- Recognition of diverse BCC subtypes is essential.
- Understanding patient history and sun exposure patterns aids diagnosis.
Main Results:
- Basal cell carcinoma presents a high incidence and growing morbidity.
- Tumor growth can lead to severe disfigurement and poor cosmetic results.
- The high rate of recurrence remains a primary challenge in managing BCC.
Conclusions:
- Accurate diagnosis, including subtype identification, is critical for effective basal cell carcinoma treatment.
- Managing the high recurrence rate is a key focus in clinical practice.
- Early detection and appropriate management can mitigate cosmetic and functional deficits.
